These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35085762)

  • 21. Pathological ventricular remodeling: therapies: part 2 of 2.
    Xie M; Burchfield JS; Hill JA
    Circulation; 2013 Aug; 128(9):1021-30. PubMed ID: 23979628
    [No Abstract]   [Full Text] [Related]  

  • 22. Current challenges in the management of heart failure.
    Komajda M
    Circ J; 2015; 79(5):948-53. PubMed ID: 25877621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crunch time for heart failure care in England and Wales.
    Lancet; 2010 Dec; 376(9758):2041. PubMed ID: 21168037
    [No Abstract]   [Full Text] [Related]  

  • 24. Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization.
    Bhagat AA; Greene SJ; Vaduganathan M; Fonarow GC; Butler J
    JACC Heart Fail; 2019 Jan; 7(1):1-12. PubMed ID: 30414818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
    Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
    Voors AA; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Ter Maaten JM; Ng L; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M
    Eur J Heart Fail; 2016 Jun; 18(6):716-26. PubMed ID: 27126231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing Baseline Metrics of Heart Failure Medication Use in Children: A Collaborative Effort from the ACTION Network.
    Stidham J; Feingold B; Almond CS; Burstein DS; Krack P; Price JF; Schumacher KR; Spinner JA; Rosenthal DN; Lorts A; Godown J
    Pediatr Cardiol; 2021 Feb; 42(2):315-323. PubMed ID: 33044586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of chronic systolic heart failure].
    Hasenfuse G; Anker SD
    Dtsch Med Wochenschr; 2013 Aug; 138(31-32):1556. PubMed ID: 23884736
    [No Abstract]   [Full Text] [Related]  

  • 29. Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials.
    Hansen MR; Hróbjartsson A; Videbæk L; Ennis ZN; Pareek M; Paulsen NH; Broe M; Olesen M; Pottegård A; Damkier P; Hallas J
    Am J Med; 2020 Jun; 133(6):e280-e289. PubMed ID: 32173347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
    Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J
    JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renin-angiotensin-aldosterone system in heart failure for the non-specialist: the past, the present and the future.
    Orsborne C; Chaggar PS; Shaw SM; Williams SG
    Postgrad Med J; 2017 Jan; 93(1095):29-37. PubMed ID: 27671772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure.
    DeVore AD; Al-Khatib SM
    JACC Heart Fail; 2019 Oct; 7(10):907-910. PubMed ID: 31521688
    [No Abstract]   [Full Text] [Related]  

  • 33. Directly Measured Adherence to Treatment in Chronic Heart Failure: LEVEL-CHF Registry.
    Jelínek L; Václavík J; Ramík Z; Pavlů L; Benešová K; Jarkovský J; Lazárová M; Janečková H; Spurná J; Táborský M
    Am J Med Sci; 2021 Apr; 361(4):491-498. PubMed ID: 33781390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
    Solomon SD; Rizkala AR; Lefkowitz MP; Shi VC; Gong J; Anavekar N; Anker SD; Arango JL; Arenas JL; Atar D; Ben-Gal T; Boytsov SA; Chen CH; Chopra VK; Cleland J; Comin-Colet J; Duengen HD; Echeverría Correa LE; Filippatos G; Flammer AJ; Galinier M; Godoy A; Goncalvesova E; Janssens S; Katova T; Køber L; Lelonek M; Linssen G; Lund LH; O'Meara E; Merkely B; Milicic D; Oh BH; Perrone SV; Ranjith N; Saito Y; Saraiva JF; Shah S; Seferovic PM; Senni M; Sibulo AS; Sim D; Sweitzer NK; Taurio J; Vinereanu D; Vrtovec B; Widimský J; Yilmaz MB; Zhou J; Zweiker R; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV
    Circ Heart Fail; 2018 Jul; 11(7):e004962. PubMed ID: 29980595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decade in review--heart failure: 10 Years of progress in HF research--what have we learned?
    Krum H
    Nat Rev Cardiol; 2014 Nov; 11(11):631-3. PubMed ID: 25178503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Programs for continuing medical education: B session; 1. The pathophysiology of heart failure--is it the disease of the heart?].
    Kitakaze M
    Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):681-6. PubMed ID: 24796136
    [No Abstract]   [Full Text] [Related]  

  • 37. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.
    Vaduganathan M; Claggett BL; Jhund PS; Cunningham JW; Pedro Ferreira J; Zannad F; Packer M; Fonarow GC; McMurray JJV; Solomon SD
    Lancet; 2020 Jul; 396(10244):121-128. PubMed ID: 32446323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
    Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic heart failure: progress in diagnosis and treatment. Topics: III. Progress in prevention, control and treatment: 3. Evidence-based pharmacologic therapy for chronic heart failure].
    Kinugawa K
    Nihon Naika Gakkai Zasshi; 2012 Feb; 101(2):379-86. PubMed ID: 22523807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.